Acurx Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Acurx Pharmaceuticals, Inc. (ACXP) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $87.41 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $87.41.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $90.28.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $90.91.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $91.65.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $87.41 10-Q · filed 2026-08-13 |
| 2026-03-31 | $90.28 10-Q · filed 2026-05-11 |
| 2025-12-31 | $90.91 10-K · filed 2026-03-12 |
| 2025-09-30 | $91.65 10-Q · filed 2025-11-12 |
| 2025-06-30 | $91.71 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.70 10-Q · filed 2025-05-12 |
| 2024-12-31 | $5.59 10-K · filed 2025-03-17 |
| 2024-09-30 | $5.68 10-Q · filed 2024-11-12 |
| 2024-06-30 | $5.77 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.92 10-Q · filed 2024-05-14 |
| 2023-12-31 | $5.98 10-K · filed 2024-03-15 |
| 2023-09-30 | $6.02 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.07 10-Q · filed 2023-08-11 |
| 2023-03-31 | $6.12 10-Q · filed 2023-05-12 |
| 2022-12-31 | $6.15 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |